Who's in Favor of Translational Cell Therapy for Stroke: STEPS Forward Please?

被引：39

作者：

Chopp, Michael ^{[2
]}

Steinberg, Gary K. ^{[3
]}

Kondziolka, Douglas ^{[4
]}

Lu, Mei ^{[2
]}

Bliss, Tonya M. ^{[3
]}

Li, Yi ^{[2
]}

Hess, David C. ^{[5
]}

Borlongan, Cesario V. ^{[1
,5
]}

机构：

[1] Univ S Florida, Dept Neurosurg, Tampa, FL 33612 USA

[2] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA

[3] Stanford Univ, Dept Neurosurg, Sch Med, Stanford, CA 94305 USA

[4] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA

[5] Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA

来源：

CELL TRANSPLANTATION | 2009年 / 18卷 / 07期

关键词：

Stem cell transplantation; Tissue regeneration; Cellular therapy; Clinical translation; ISCHEMIC CORTEX; TRANSPLANTATION; NEURONS; RATS;

D O I：

10.3727/096368909X470883

中图分类号：

Q813 [细胞工程];

学科分类号：

100113 [医学细胞生物学];

摘要：

A consortium of translational stem cell and stroke experts from multiple academic institutes and biotechnology companies, under the guidance of the government (FDA/NIH), is missing. Here, we build a case for the establishment of this consortium if cell therapy for stroke is to advance front the laboratory to the clinic

引用

页码：691 / 693

页数：3

共 6 条

[1]

Transplantation of hNT neurons into the ischemic cortex: Cell survival and effect on sensorimotor behavior [J].